We’re excited to share that our VP of Clinical Development, Nitin Patel, and Sarah Snykers, Sr. Director of Operations at Legend, will be presenting at the NextGen Biomed by Oxford Global #Cell2025 event in London, taking place November 10-12! They’ll explore the clinical and commercial manufacturing readiness of our #CART #CellTherapy, sharing key insights from late-stage development and how #CellTherapies are advancing toward broader clinical adoption and commercial scale-up. See the agenda and discover more about the conference: https://lnkd.in/g2vP-yEb
This is the exact conversation the field needs. Bridging the gap between groundbreaking clinical data and scalable, reliable manufacturing is the final frontier for cell therapy. Looking forward to hearing Legend's insights on making these treatments accessible to all.